71 reports

Muscle Invasive Bladder Cancer (MIBC) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary clinical trial report, “Muscle Invasive Bladder Cancer (MIBC) Clinical Trial Analysis by Trial Phase, Trial Status, Trial...

  • Bladder Cancer
  • Clinical Trial
  • World

Muscle Invasive Bladder Cancer (MIBC) - Global Clinical Trials Review, H2, 2021 Summary clinical trial report, “Muscle Invasive Bladder Cancer (MIBC) - Global Clinical Trials Review, H2, 2021" provides an overview of Muscle Invasive Bladder Cancer (MIBC) Clinical trials scenario. This report provides...

  • Bladder Cancer
  • Clinical Trial
  • World

Major players in the bladder cancer drugs market are Pfizer, Celgene Corporation, Eli Lilly, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Sanofi, Hoffmann-La Roche, Novartis International and Johnson & Johnson. The global bladder cancer drugs market is expected to grow from $1.98 billion in 2021 to $2.35 billion in 2022 at a...

  • Bladder Cancer
  • World
  • United States
  • Biologics Penetration Rate
  • Smoking Prevalence

Bladder Cancer (Oncology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer - Drugs In Development, 2021, provides an overview of the Bladder Cancer (Oncology) pipeline landscape. Bladder cancer occurs in tissues of the urinary...

  • Bladder Cancer
  • World

Bladder Cancer Therapeutics and Diagnostics market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Bladder Cancer Therapeutics and Diagnostics Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Bladder Cancer...

  • Diagnostics
  • Bladder Cancer
  • World

Major players in the bladder cancer drugs market are Pfizer, Celgene Corporation, Eli Lilly, AstraZeneca, and Bristol-Myers Squibb. The global bladder cancer drugs market is expected to grow from $0.98 billion in 2020 to $1.14 billion in 2021 at a compound annual growth rate (CAGR) of 16.3%. The growth is mainly due to the companies...

  • Bladder Cancer
  • United States
  • Biologics Penetration Rate
  • Smoking Prevalence

Abstract: - Global Bladder Cancer Therapeutics Market to Reach $308.2 Million by 2027 - Amid the COVID-19 crisis, the global market for Bladder Cancer Therapeutics estimated at US$242.6 Million in the year 2020, is projected to reach a revised size of US$308.2 Million by 2027, growing at a CAGR of 3.5% over the analysis...

  • Bladder Cancer
  • World
  • China
  • United States

Bladder Cancer Therapeutics and Diagnostics Market Report Overview Bladder Cancer Therapeutics and Diagnostics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Bladder Cancer Therapeutics and Diagnostics market types and applications....

  • Diagnostics
  • Bladder Cancer
  • World
  • Health Provider Density

China’s demand for Bladder Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export,...

  • Bladder Cancer
  • China
  • Industrial Production
  • Hospital Beds Number

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Global Clinical Trials Review, H1, 2020 Summary This clinical trial report, “Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Global Clinical Trials Review, H1, 2020" provides an overview of Non Muscle...

  • Bladder Cancer
  • Clinical Trial
  • G7
  • APAC

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncology) - Drugs in Development, 2021 Summary Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncology) - Drugs in Development, 2021 provides an overview of the Non Muscle Invasive Bladder Cancer (NMIBC)...

  • Bladder Cancer
  • World

Muscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021 Summary Muscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021 provides an overview of the Muscle Invasive Bladder Cancer (MIBC) pipeline landscape. The report provides comprehensive information...

  • Bladder Cancer
  • World

Bladder Cancer - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer - Pipeline Review, H1 2020, provides an overview of the Bladder Cancer (Oncology) pipeline landscape. Bladder cancer occurs in tissues of the urinary bladder....

  • Bladder Cancer
  • World

Bladder Cancer: Epidemiology Forecast to 2028 Summary The financial burden of diagnosed bladder cancer is expected to grow between 2018 and 2028 in the seven major markets (The US, France, Germany, Italy, Spain, the UK and Japan) due to an increase in disease incident cases from over 225,000 to...

  • Bladder Cancer
  • World
  • Smoking Prevalence
  • Cancer Incidence

The Urology Laser Market was valued at approximately USD 944.79 million in 2020 and is expected to witness a revenue of USD 1,295.24 million in 2026, with a CAGR of 5.51% over the forecast period. COVID-19 pandemic is expected to have a significant impact on the growth of the studied market. In addition to the effects of the Coronavirus...

  • Genitourinary System Disease
  • Bladder Cancer
  • Rare Earth
  • Surgical Laser
  • World
  • Europe
  • South America
  • APAC
  • Middle East
  • Africa
  • Health Expenditure
  • Cause-Specific Mortality Rate

Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass...

  • Autoimmune Disease
  • Bladder Cancer
  • World
  • Life Expectancy

INTRODUCTION According to the World Health Organization, in a year, around 2 million to 3 million individuals suffer from various forms of skin cancers, across the globe. This type of cancer account for 33% of all the diagnosed tumors, globally. It is also worth highlighting that one in every five Americans is likely to...

  • Cancer
  • Dermatological Condition
  • Lung Cancer
  • Bladder Cancer
  • Clinical Trial
  • Ear, Nose, And Throat Medicine
  • World
  • APAC
  • Europe
  • North America

Ostomy Drainage Bags Market By Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Ileostomy Bags, Continent Urostomy Bags): Global Opportunity Analysis and Industry Forecast, 2020-2030 The ostomy drainage bags market was valued at $1,658.38 million in 2020, and is estimated to reach $2,409.38 million by...

  • Healthcare
  • Medical Supply
  • Oncology
  • Colorectal Cancer
  • Bladder Cancer
  • Caring Services
  • Digestive System Disorder
  • World

Bladder Cancer - Pipeline Review, H2 2019 Summary The latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer - Pipeline Review, H2 2019, provides an overview of the Bladder Cancer (Oncology) pipeline landscape. Bladder cancer occurs in tissues of the urinary bladder....

  • Bladder Cancer
  • World

Global Urine Flow Meters Market 2022-2026 The analyst has been monitoring the urine flow meters market and it is poised to grow by $ 29.61 mn during 2022-2026, progressing at a CAGR of 6.70% during the forecast period. Our report on the urine flow meters market provides a holistic analysis, market size and forecast, trends,...

  • Bladder Cancer
  • Marketing Research
  • World

Tyrosine Protein Kinase Receptor TYRO3 - Pipeline Review, H2 2019 Summary Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) - Tyrosine-protein...

  • Bladder Cancer
  • World
  • Industrial Production

This study focuses on China’s Bladder Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy....

  • Bladder Cancer
  • China
  • Employment Costs
  • Business Birth

This study focuses on China’s Bladder Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Bladder Cancer
  • China
  • Industrial Production
  • Labour Force

The Global Urinary Drainage Bags Market size is expected to reach $2.3 billion by 2026, rising at a market growth of 5.7% CAGR during the forecast period. Urine drainage bags collect urine and are mostly used in hospitals. This bag is designed in such a way that it is attached to a catheter (tube) or sheath that is put inside the urinary bladder...

  • Genitourinary System Disease
  • Catheter
  • Renal Disease
  • Dementia
  • Bladder Cancer
  • Marketing Research
  • Urology
  • Incontinence Product
  • Chronic Disease
  • Urology Device
  • World

CD40 Ligand - Pipeline Review, H2 2019 Summary CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - CD40 ligand or CD40L is a protein that is primarily expressed on activated T cells and is a member of the TNF...

  • Gene Therapy
  • Pharmaceutical
  • Vaccine
  • Breast Cancer
  • Bladder Cancer
  • World
  • Stem Cell Transplantation

Baculoviral IAP Repeat Containing Protein 5 - Pipeline Review, H2 2019 Summary Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) pipeline Target constitutes close to 20 molecules. Out of which approximately 14 molecules are developed by companies...

  • Cancer
  • Therapy
  • Vaccine
  • Oncology
  • Oncology
  • Bladder Cancer
  • World
  • United Kingdom
  • Prescription Drug Sales

Summary Numares AG (Numares), formerly Numares GmbH, is a developer and marketer of products for life science research and clinical diagnostics.The company’s AXINON lipoFIT, a test system used for lipoprotein profiling, while insightLP provides insights into lipid related research using lipoprotein composition analysis. It...

  • Diagnostics
  • Bladder Cancer
  • Clinical Trial
  • World
  • Europe
  • United States
  • Medical Devices Sales

Summary GenomicTree Co Ltd (GenomicTree) is a medical device company that develops and commercializes diagnostic products for the screening and diagnosis of cancer.The company also provides non-invasive cancer molecular diagnostic product. Its products are used in the detection of colorectal, lung and bladder cancer.GenomicTree’s...

  • Cancer
  • Clinical Trial
  • Bladder Cancer
  • South Korea
  • East Asia
  • Colorectal Cancer Screening Coverage
  • Medical Devices Sales

Summary IncellDx Inc (IncellDx) is a single cell diagnostic company that develops transformative diagnostic and prognostic clinical patient information technologies.The company detects and monitors life threatening viral diseases in the areas of cervical cancer, HIV and AIDS, hepatitis, and organ transplant rejection. Its...

  • Infectious Disease
  • Breast Cancer
  • Artificial Intelligence
  • Ovarian Cancer
  • Bladder Cancer
  • Clinical Trial
  • World
  • United States
  • China
  • North America
  • Medical Devices Sales

Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) - Pipeline Review, H1 2019 Summary Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine...

  • Bladder Cancer
  • World
  • Industrial Production